TickerFactsScreenerDevelopers

Pacira BioSciences, Inc. (PCRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $12.39M2009: $7.08M2010: $26.13M2011: $46.17M2012: $12.52M2013: $12.52M2014: $37.52M2015: $56.98M2016: $35.94M2017: $54.13M2018: $132.53M2019: $78.23M2020: $99.96M2021: $585.58M2022: $104.14M2023: $153.30M2024: $276.77M2025: $158.54M$158.54M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$158.54M-42.7%
2024$276.77M+80.5%
2023$153.30M+47.2%
2022$104.14M-82.2%
2021$585.58M+485.8%
2020$99.96M+27.8%
2019$78.23M-41.0%
2018$132.53M+144.8%
2017$54.13M+50.6%
2016$35.94M-36.9%
2015$56.98M+51.9%
2014$37.52M+199.8%
2013$12.52M+0.0%
2012$12.52M-72.9%
2011$46.17M+76.7%
2010$26.13M+269.3%
2009$7.08M-42.9%
2008$12.39M—